Get the Stockscreener App
0.262
2.31%
-0.0062
Pre-market:
.25
-0.012
-4.58%
Nexgel Inc stock is traded at $0.262, with a volume of 235.56K.
It is down -2.31% in the last 24 hours and down -31.05% over the past month.
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies.
See More
Previous Close:
$0.2682
Open:
$0.27
24h Volume:
235.56K
Relative Volume:
0.35
Market Cap:
$2.55M
Revenue:
$11.26M
Net Income/Loss:
$-3.09M
P/E Ratio:
-0.6535
EPS:
-0.4009
Net Cash Flow:
$-1.49M
1W Performance:
+1.16%
1M Performance:
-31.05%
6M Performance:
-61.58%
1Y Performance:
-89.17%
1-Day Range:
$0.25
$0.2796
1-Week Range:
$0.25
$0.2838
52-Week Range:
$0.24
$2.8899
Nexgel Inc Stock (NXGL) Company Profile
Name
Nexgel Inc
Sector
Industry
Phone
215 702-8550
Address
2150 CABOT BLVD WEST,, LANGHORNE
Compare NXGL vs ISRG, BDX, RMD, ALC, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NXGL
Nexgel Inc
|
0.262 | 2.55M | 11.26M | -3.09M | -1.49M | -0.4009 |
ISRG
Intuitive Surgical Inc
|
399.52 | 141.14B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
179.23 | 48.82B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
221.89 | 32.01B | 5.54B | 1.52B | 1.74B | 10.37 |
ALC
Alcon Inc
|
64.56 | 31.21B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
34.66 | 30.41B | 29.14B | 1.07B | 1.05B | 1.1956 |
Nexgel Inc Stock (NXGL) Latest News
NXGL: Proposed reorganization consolidates assets, divests consumer lines, and targets profitability - TradingView
NexGel Shareholders Approve Stock Expansion and Split - The Globe and Mail
NexGel Announces Strategic Review and Platform Reorganization - TipRanks
NexGel begins using strategic review presentation on proposed platform reorganization - TradingView
A strategic review is the focus of a new shareholder presentation from NexGel (NXGL). - Stock Titan
NexGel shareholders approve share increase and reverse stock split proposals - Investing.com Canada
Form 8K Nexgel Inc For: 23 September - Investing.com India
Form 8K Nexgel Inc For: 23 September By Investing.com - Investing.com Canada
NEXGEL Announces Dial-In Details for Investor Update Call - The Manila Times
NEXGEL Sets Sept. 24 Investor Call to Detail Operations - mychesco.com
NEXGEL Announces Date for Investor Update Call - The Manila Times
NexGel (NXGL) Dips 3.07% to $0.35; Traders Eye $0.33 SupportBlock Trade Flow - vinanet.vn
NexGel Inc (NXGL) Holds at $0.35 as Buyers Defend Support, Resistance Looms at $0.37Sector Neutral Pair - siam.in
NXGL Q2 2026 Earnings: EPS Falls Short of Estimates by Wide MarginBuyback Announcement Report - vinanet.vn
NEXGEL Reports Positive Data from Randomized Single-Center IRB Study to Evaluate the Effectiveness and Safety of a Hydrogel Laser Treatment Patch in Laser Hair Removal with a 95.6% Reduction in Plume Concentration - Barchart.com
NexGel Inc Warrant (NXGLW) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
NexGel Inc Warrant (NXGLW) Key Financial Ratios – Valuation, Profitability & More - Value Research
Maxim Downgrades NexGel to Hold From Buy - marketscreener.com
NEXGEL (NXGL) terminates CEO and launches broad strategic review - Stock Titan
NEXGEL Names Brian Kieser Interim CEO, Launches Strategic Review - citybiz
symbol__ Stock Quote Price and Forecast - CNN
Deal Dispatch: MunichRe Buys At-Bay, Mavis Tire Closes Pep Boys Purchase, Werewolf Merges With Ambros - Benzinga
Nexgel, Inc. Forms Special Committee to Oversee Comprehensive Strategic Review and Value Creation - marketscreener.com
NEXGEL Appoints Brian Kieser To Replace CEO Adam Levy Effective August 21 - tradingview.com
NEXGEL ANNOUNCES LEADERSHIP TRANSITION AND STRATEGIC REVIEW INITIATIVE - GlobeNewswire
NexGel Files to Register 15.25 Million Shares From Note Conversions - marketscreener.com
NexGel (NXGL) Earnings Report: The EPS Result Is Below Expectation in the Latest Session; Post-Earnings: Shares Move 5.05% Up in the Latest ReadingEarnings Call Transcript - dars.gov.et
NXGL | NexGel, Inc Common Stock FinancialsRevenue Breakdown - Quiver Quantitative
NexGel (NXGL) Results at a Glance: The Bottom-Line Figure Trails Its Comparison in the Available Record; Share Response: Shares Finish 5.05% Up in Latest TradingEarnings Season Outlook - dars.gov.et
NexGel (NXGL) Earnings Brief: EPS Does Not Reach the Reported Estimate at the Close; Session Reaction - vinanet.vn
NexGel (NXGLW) Session Check: Records a 33.33% Increase to $0.02 in the Latest Reading; Level Check: the Session Ends Within the Reported Technical Boundaries in the Latest SessionCumulative Volume - vinanet.vn
Nexgel earnings missed by $0.30, revenue topped estimates - Investing.com Canada
Dow Falls 150 Points; NY Empire State Manufacturing Index Rises In August - Sahm
Gold Gains 1%; NY Empire State Manufacturing Index Rises In August - Sahm
NexGel (NXGLW) Session Check: Records a 33.33% Increase to $0.02 in the Latest Reading - siam.in
Nexgel’s Celularity Deal: Execution, Integration, and Profitability Risks from $13.3 Million Biomaterials Acquisition - TipRanks
NexGel Q2 FY26 gross profit falls 11.84% to $1.11 million; revenue rises 27.8% to $3.69 million - Bitget
NEXGEL Q2 Revenue Reaches $3.69 Million as BioNX Integration Faces Slower Ramp - Yahoo Finance
NexGel Q2 Loss Widens Sharply on $2.2M Interest and Derivative Charges - minichart.com.sg
Form 8K Nexgel Inc For: 17 August By Investing.com - Investing.com Nigeria
NXGL: Q2 revenue reached $3.69M with a $2.87M net loss; integration and expansion efforts continue - TradingView
NEXGEL Q2 2026: Revenue $3.69M, Net Loss $2.87M as Company Transitions Post-Acquisition - TradingView
NEXGEL, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
NEXGEL Reports Second Quarter 2026 Financial Results - The Manila Times
NEXGEL's Surgical Business Has a $795,000 Backlog—What's Holding It Up? - Stock Titan
NXGL Q2'26 Earnings: EPS estimate is (0.12) USD - TradingView
NEXGEL, INC. Q2 2026: Revenue $3.69M, EPS $(0.40) — 10-Q Summary - TradingView
NexGel (NXGL) pushes back Q2 report, cites audit review - Stock Titan
NexGel (NXGL) issues going‑concern warning after Q2 loss - Stock Titan
NexGel (NXGL) plans big share authorization boost and reverse split to protect Nasdaq listing - Stock Titan
NEXGEL, Inc. (NASDAQ:NXGL): Are Analysts Optimistic? - simplywall.st
Nexgel Inc Stock (NXGL) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.23%
3.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):